In several preclinical studies, researchers have demonstrated CSF1-CSF1R signaling blockade slowed primary tumor growth, reduced metastatic potential, and improved long-term survival of tumor-bearing mice [120,121,122]. The gene discussed is CSF1R; the disease is neoplasm.